Información del artículo
El síndrome “prostatitis” representa una entidad nosológica con una prevalencia muy relevante y, por tanto, con unas connotaciones enormes en cuanto a impacto económico, sanitario y de calidad de vida para los pacientes. Con una sintomatología ambigua, métodos de diagnóstico controvertidos y tratamientos largos y de resultados irregulares, se ha convertido en una de esas patologías que, sin comprometer la vida del paciente, resultan un tanto incómodas tanto para el paciente como para el profesional que intenta ayudarle y no siempre lo consigue. Aunque en la mayoría de los casos se acepta una etiología infecciosa, existen serias controversias tanto respecto a los métodos diagnósticos utilizados como a la interpretación de los mismos. Recientemente, el National Institutes of Health de Estados Unidos ha propuesto una nueva clasificación de esta patología que sustituye a la otra vigente en los últimos 20 años y que, en principio, permitiría una mejor aproximación al diagnóstico y tratamiento de esta patología tan insidiosa.
Palabras clave:
Prostatitis
Prostatitis aguda
Prostatitis crónica
Síndrome doloroso pelviano crónico
Prostatitis is a highly prevalent nosologic entity and hence has an enormous financial impact on health systems as well as negative repercussions on patients’ quality of life. The symptoms are ambiguous, diagnostic methods are controversial and treatments are long and produce inconsistent results; consequently, although not life-threatening, prostatitis has become one of those diseases that is difficult both for the patient and for the physician who attempts to help, sometimes without success. Although an infectious etiology is accepted in most cases, there are major controversies about both the diagnostic methods used and their interpretation. Recently the National Institutes of Health in the USA has proposed a new classification of this disease to substitute that used for the last twenty years. This new classification may provide a more effective approach to the diagnosis and treatment of this insidious disease.
Key words:
Prostatitis
Acute prostatitis
Chronic prostatitis
Chronic pelvic pain syndrome
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.N. Krieger, S.O. Ross, L. Deutsch, D.E. Riley.
Seminal fluid analysis in chronic prostatitis/chronic pelvic pain syndrome.
Andrologia, 35 (2003), pp. 266-270
[2.]
J.C. Nickel, J. Downey, D. Hunter, J. Clark.
Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index.
J Urol, 165 (2001), pp. 842-845
[3.]
J.N. Krieger, D.E. Riley, P.Y. Cheah, M.L. Liong, K.H. Yuen.
Epidemiology of prostatitis: new evidence for a world-wide problem.
World J Urol, 2 (2003), pp. 70-74
[4.]
García-Ortells D, Navío S, Sanz E, Gómez I, García R. Epidemiología y demografía de la prostatitis. Urol Integr Invest. 200;9:99-104.
[5.]
R.O. Roberts, D.J. Jacobson, C.J. Girman, T. Rhodes, M.M. Lieber, S.J. Jacobsen.
Prevalence of prostatitis-like symptoms in a community based cohort of older men.
J Urol, 168 (2002), pp. 2467-2471
[6.]
M. McNaughton-Collins, J.B. Meigs, M.J. Barry, E. Walker, E. Giovannucci, I. Kawachi.
Prevalence and correlates of prostatitis in the health professionals follow-up study cohort.
J Urol, 167 (2002), pp. 1363-1366
[7.]
M.S. Litwin, M. McNaughton-Collins, F.J. Fowler, J.C. Nickel, E.A. Calhoun, M.A. Pontari, et al.
The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network.
J Urol, 162 (1999), pp. 369-375
[8.]
A. Mehik, P. Hellstrom, O. Lukarinen, A. Sarpola, M. Jarvelin.
Epidemiology of prostatitis in Finnish men: a population based cross-sectional study.
BJU Int, 86 (2000), pp. 443-448
[9.]
G.W. Drach, E.M. Meares, W.R. Fair, T.A. Stamey.
Classification of benign disease associated with prostatic pain prostatitis or prostatodynia.
J Urol, 120 (1978), pp. 266-276
[10.]
J.N. Krieger, L. Nyberg, J.C. Nickel.
NIH consensus definition and classification of prostatitis.
JAMA, 282 (1999), pp. 236-237
[11.]
B.S. Carver, C.B. Bozeman, B.J. Williams, D.B. Venable.
The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen.
J Urol, 169 (2003), pp. 589-591
[12.]
W. Hochreiter, S. Z’Brun, W.W. Hochreiter.
Síndrome del dolor pélvico crónico y disfunción del vaciado.
Curr Urol Reports, 4 (2005), pp. 15-20
[13.]
P. Hruz, H. Danuser, U.E. Studer.
Non-inflammatory chronic pelvic pain syndrome can be caused by bladder neck hypertrophy.
Eur Urol, 44 (2003), pp. 106-110
[14.]
R.S. Kirby, D. Lowe, M.I. Bultitude, K.E. Shuttleworth.
Intraprostatic urinary reflux: an etiological factor in abacterial prostatitis.
Br J Urol, 121 (1982), pp. 729-731
[15.]
B.E. Persson, G. Ronquist.
Evidence for a mechanistic association between non-bacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion.
J Urol, 155 (1996), pp. 958-960
[16.]
J.E. McNeal.
Regional morphology and pathology of the prostate.
Amer J Clin Path, 49 (1968), pp. 347-357
[17.]
J.C. Nickel, J.W. Costerton.
Bacterial localization in antibiotic refractory chronic bacterial prostatitis.
Prostate, 23 (1993), pp. 107-114
[18.]
M. Ludwig, C. Steltz, P. Huwe, R. Schaffer, M. Altmannsberger, W. Weidner.
Immunocytological analysis of leukocyte subpopulations in urine specimens before and after prostatic massage.
Eur Urol, 39 (2001), pp. 277-282
[19.]
R.B. Nadler, A.E. Koch, E.A. Calhoun, P.L. Campbell, D.L. Pruden, C.L. Bennett, et al.
IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis.
J Urol, 164 (2000), pp. 214-218
[20.]
J.N. Krieger, K.J. Egan, S.O. Ross, R. Jacobs, R. Berger.
Chronic pelvic pains represent the most prominent urogenital symptoms of “chronic prostatitis”.
Urology, 48 (1996), pp. 715-772
[21.]
J.L. Miller, I. Rothman, T.G. Bavendam, R.E. Berger.
Prostatodynia and interstitial cystitis: one and the same?.
Urology, 45 (1995), pp. 587-590
[22.]
J.Q. Clemens, R.B. Nadler, A.J. Schaeffer, J. Belani, J. Albaugh, W. Bushman.
Biofeedback, pelvic floor reeducation and bladder training for male chronic pelvic pain syndrome.
Urology, 56 (2000), pp. 951-955
[23.]
D.C. Hetrick, M.A. Ciol, I. Rothman, J.A. Turner, M. Forest, R.I. Berger.
Musculoeskeletal dysfunction in men with chronic pelvic pain syndrome type III: a case control study.
J Urol, 170 (2003), pp. 828-831
[24.]
C.C. Yang, J.C. Lee, B.G. Kromm, M.A. Ciol, R.E. Berger.
Pain sensitization in male chronic pelvic pain syndrome: why are symptoms so difficult to treat?.
J Urol, 170 (2003), pp. 823-826
[25.]
C. Pavone, E. Caldarera, P. Liberti, V. Miceli, D. Di Trapani, V. Serretta, et al.
Correlation between chronic prostatitis syndrome and pelvic venous disease: a survey of 2,554 urologic outpatients.
Eur Urol, 37 (2000), pp. 400-403
[26.]
E. Screponi, E. Carosa, S.M. Di Stasi, M. Pepe, G. Carruba, E.A. Jannini.
Prevalence of chronic prostatitis in men with premature ejaculation.
Urology, 58 (2001), pp. 198-202
[27.]
N. Cruz, J. Sáenz, S. Navío.
Perspectiva histórica de la clasificación y diagnóstico clínico de las prostatitis.
Urol Integr Invest, 9 (2004), pp. 105-112
[28.]
E.M. Meares, T.A. Stamey.
Bacteriological localization patterns in bacterial prostatitis and urethritis.
Invest Urol, 5 (1968), pp. 492-518
[29.]
K.G. Naber, W. Busch, J. Focht.
Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostatitis Study Group.
Int J Antimicrob Agents, 14 (2000), pp. 143-149
[30.]
H. Kiyota, S. Onodera, Y. Ohishi, T. Tsukamoto, T. Matsumoto.
Questionnaire survey of Japanese urologists concerning the diagnosis and treatment of chronic prostatitis and chronic pelvic pain syndrome.
Int J Urol, 10 (2003), pp. 636-642
[31.]
J.C. Nickel.
The pre and postmasage test (PPMT): a simple screen for prostatitis.
Tech Urol, 3 (1997), pp. 38-43
[32.]
D.F. Mobley.
Semen cultures in the diagnosis of bacterial prostatitis.
J Urol, 114 (1975), pp. 83-85
[33.]
Jiménez Cruz JF, Moreno B, Mascarós E, Acosta B, Gobernado M. Prostatitis crónica. Diagnóstico microbiológico. Act Urol Esp. 1988; Monográfico Infecciones Urinarias: 58-62.
[34.]
J.L. Palmero, A. Budía, A. Benedicto, J.A. Queipo, E. Broseta, J.F. Jiménez Cruz.
Stamey-Meares tests in chronic prostatitis diagnosis.
Is still a valid procedure? Europ Urol, 15 (2003),
[35.]
G.J. Domingue, W.J.G. Hellstrom.
Prostatitis.
Clinic Microb Reviews, 11 (1998), pp. 604-613
[36.]
A.R. Shahed, D.A. Shoskes.
Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response.
J Androl, 21 (2000), pp. 669-675
[37.]
M. Ohkawa, K. Yamaguchi, S. Tokunaga, T. Nakashima, S. Fujita.
Ureaplasma urealyticum in the urogenital tract of patients with chronic prostatitis or related symptomatology.
Br J Urol, 72 (1993), pp. 918-921
[38.]
R.R. Badalyan, S.V. Fanarjyan, I.G. Aghajanyan.
Chlamydial and ureaplasmal infections in patients with nonbacterial chronic prostatitis.
Andrologia, 35 (2003), pp. 263-265
[39.]
J.N. Krieger, R.R. Jacobs, S.O. Ross.
Does the chronic prostatitis/pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia?.
J Urol, 165 (2000), pp. 1554-1558
[40.]
A.J. Schaeffer.
Epidemiology and demographics of prostatitis.
Andrologia, 35 (2003), pp. 252-257
[41.]
J.C. Nickel, R.B. Alexander, A.J. Schaeffer, J.R. Landis, J.S. Knauss, K.J. Propert.
Chronic Prostatitis Collaborative Research Network Study Group. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls.
J Urol, 170 (2003), pp. 818-822
[42.]
D. Lorence, S. Villanueva.
Citología inflamatoria en la prostatitis crónica (CP/CPPS).
Urol Integr Invest, 9 (2004), pp. 127-132
[43.]
R. Rodríguez Patrón, T. Mayayo, E. Sanz.
Técnicas de imagen en patología inflamatoria prostática.
Urol Integr Invest, 9 (2004), pp. 133-139
[44.]
V. Pansadoro, P. Emiliozzi, L. Defidio, P. Scarpone, G. Sabatini, A. Brisciani, et al.
Prostate-specific antigen and prostatitis in men under fifty.
Eur Urol, 30 (1996), pp. 24-27
[45.]
S. Kravchick, S. Cytron, L. Agulansky, D. Ben-Dor.
Acute prostatitis in middle-aged men: a prospective study.
BJU Int, 93 (2004), pp. 93-96
[46.]
R.B. Alexander, S. Ponniah, J. Hasday, J.R. Hebel.
Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome.
Urology, 52 (1998), pp. 744-749
[47.]
L.D. True, R.E. Berger, I. Rothman, S.O. Ross, J.N. Krieger.
Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study.
J Urol, 162 (1999), pp. 2014-2018
[48.]
J. Dimitrakov, T. Diemer, M. Ludwig, W. Weidner.
Recent developments in diagnosis and therapy ofthe prostatitis syndromes.
Curr Op Urol, 11 (2001), pp. 87-91
[49.]
J.F. Jiménez Cruz, E. Broseta, et al.
Bladder neck obstruction.
Textbook of genitourinary surgery, pp. 532-546
[50.]
J.C. Nickel.
Classification and diagnosis of prostatitis: a gold standard?.
Andrologia, 35 (2003), pp. 160-167
[51.]
J.N. Krieger.
Prostatitis revisited: new definitions, new approaches.
Infect Dis Clin North Am, 17 (2003), pp. 395-409
[52.]
A. Elert, R. Von Knobloch, R. Nusser, A. Heidenreich, R. Hofmann.
Isolated candidal prostatitis.
J Urol, 163 (2000), pp. 244
[53.]
D.A. Shoskes.
Use of antibiotics in chronic prostatic syndromes.
Can J Urol, 8 (2001), pp. 24-28
[54.]
K. Charalabopoulos, G. Karachalios, D. Baltogiannis, A. Charalabopoulos, X. Giannakopoulos, N. Sofikitis.
Penetration of antimicrobial agents into the prostate.
Chemotherapy, 49 (2003), pp. 269-279
[55.]
J. Khastgir, A.J. Dickinson.
Where do we stand with chronic prostatitis? An update.
Hosp Med, 64 (2003), pp. 732-736
[56.]
L. Baert, A. Leonard.
Chronic bacterial prostatitis: 10 years of experience with local antibiotics.
J Urol, 140 (1988), pp. 755-757
[57.]
J.F. Jiménez Cruz, F. Boronat, J. Gallego.
Treatment of chronic prostatitis: Intraprostatic antibiotic injections under echographic control.
J Urol, 139 (1988), pp. 967-970
[58.]
J.C. Nickel, J. Downey, B. Johnston, J. Clark, T.C. Group, The Canadian Prostatitis Research Group.
Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial.
J Urol, 165 (2001), pp. 1539-1544
[59.]
J.C. Nickel, J. Downey, J. Clark, R.W. Casey, P.J. Pommerville, J. Barkin, et al.
Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.
Urology, 62 (2003), pp. 614-617
[60.]
L. Olavi, L. Make, M. Imo.
Effects of finasteride in patients with chronic idiopathic prostatitis: a double-blind placebo-controlled pilot study.
Eur Urol, 33 (1998), pp. 24-29
[61.]
G.A. Barbalias, G. Nikiforidis, E.N. Liatsikos.
α-blockers for the treatment of chronic prostatitis in combination with antibiotics.
J Urol, 159 (1998), pp. 883-887
[62.]
J.C. Nickel.
Prostatitis: evolving management strategies.
Urol Clin North Am, 26 (1999), pp. 737-751
[63.]
V. Oschepkov, A. Sivkov, E. Dary.
Efficacy of transrectal microwave hyperthermia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study [abstract 115].
J Urol, 161 (1999), pp. 333
[64.]
E.N. Liatsikos, C.Z. Dinlec, R. Kapoor, A.D. Smith.
Transurethral microwave thermotherapy for the treatment of prostatitis.
J Endourol, 14 (2000), pp. 689-692
[65.]
S.A. Kaplan, M.A. Volpe, A.E. Te.
A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.
J Urol, 171 (2004), pp. 284-288
[66.]
Y. Evliyaoglu, R. Burgut.
Lower urinary tract symptoms, pain and quality of life assessment in chronic non-bacterial prostatitis patients treated with alpha-blocking agent doxazosin; versus placebo.
Int Urol Nephrol, 34 (2002), pp. 351-356
[67.]
D.A. Shoskes, K. Manickam.
Herbal and complementary medicine in chronic prostatitis.
World J Urol, 21 (2003), pp. 109-113
[68.]
R.U. Anderson, D. Wise, M. Meadows.
Myofascial release therapy for category III chronic prostatitis.
J Urol, 161 (1999), pp. 34-39
[69.]
H. Merskey.
Pharmacological approaches other than opioids in chronic non-cancer pain management.
Acta Anaesthesiol Scand, 41 (1997), pp. 187-191
[70.]
D.A. Shoskes, L. Hakim, G. Ghoniem, C.L. Jackson.
Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome.
J Urol, 169 (2003), pp. 1406-1410
[71.]
S. Merahn.
Prostatitis.
PDxMD renal and genitourinary disorders, Elsevier, (2003),
[72.]
S. Lacquanti, V. Fulcoli, J.M. Weir, F. Pisanti, C. Servello, A. Destito.
Bacterial prostatitis: urine and spermatic urine culture.
Arch Ital Urol Androl, 72 (2000), pp. 21-23
[73.]
A. Elert, R. Von Knobloch, R. Nusser, A. Heidenreich, R. Hofmann.
Isolated candidal prostatitis.
J Urol, 163 (2000), pp. 244
[74.]
R. Seo, R. Oysau, A. Schaeffer.
Blastomycosis of the epididymis and prostate.
Urology, 50 (1997), pp. 980-982
Copyright © 2005. Elsevier España S.L.. Todos los derechos reservados
